Serum neutrophil gelatinase-associated lipocalin levels are correlated with the complexity and the severity of atherosclerosis in acute coronary syndrome

Anadolu Kardiyoloji Dergisi

Volumn 15, Issue 6, 2015, Pages 450-455

  Soylu, Korhan ^a   Aksan, Gökhan ^b   Nar, Gökay ^c   Özdemir, Metin ^b   Gülel, Okan ^a   İnci, Sinan ^c   Aksakal, Aytekin ^d   Soylu, Ayşegül İdil ^d   Yılmaz, Özcan ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b Gazi State Hospital Samsun   (Turkey)

^c Aksaray State Hospital   (Turkey)

^d SAMSUN TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Gensini; GRACE; Neutrophil gelatinase associated lipocalin; Non ST elevation acute coronary syndrome; SYNTAX

Indexed keywords

C REACTIVE PROTEIN; CREATININE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TRIACYLGLYCEROL; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN; TROPONIN T;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENSINI RISK SCORE; GRACE RISK SCORE; HEART EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; ST SEGMENT DEPRESSION; SYNTAX RISK SCORE; ACUTE CORONARY SYNDROME; BLOOD; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; EVALUATION STUDY; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX; CLINICAL ARTICLE; HEART LEFT VENTRICLE EJECTION FRACTION; ST SEGMENT ELEVATION;

ACUTE CORONARY SYNDROME; ACUTE-PHASE PROTEINS; BIOMARKERS; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; LIPOCALINS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS; SEVERITY OF ILLNESS INDEX;

EID: 84979097851     PISSN: 13028723     EISSN: 13080032     Source Type: Journal    
DOI: 10.5152/akd.2014.5513     Document Type: Article

References (28)

1. Ikonomidis I, Michalakeas CA, Parissis J, Paraskevaidis I, Ntai K, Papadakis I, et al. Inflammatory markers in coronary artery disease. Biofactors 2012; 38: 320-8. [CrossRef]
2. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993; 268: 10425-32.
3. Yndestad A, Landrø L, Ueland T, Dahl CP, Flo TH, Vinge LE, et al. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur Heart J 2009; 30: 1229-36. [CrossRef]
4. Ding L, Hanawa H, Ota Y, Hasegawa G, Hao K, Asami F, et al. Lipocalin-2 neutrophil gelatinase-B associated lipocalin is strongly induced in hearts of rats with autoimmune myocarditis and in human myocarditis. Circ J 2010; 74: 523-30. [CrossRef]
5. Hemdahl AL, Gabrielsen A, Zhu C, Eriksson P, Hedin U, Kastrup J, et al. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol 2006; 26: 136-42. [CrossRef]
6. Choi KM, Lee JS, Kim EJ, Baik SH, Seo HS, Choi DS, et al. Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. Eur J Endocrinol 2008; 158: 203-7. [CrossRef]
7. Zografos T, Haliassos A, Korovesis S, Giazitzoglou E, Voridis E, Katritsis D. Association of neutrophil gelatinase-associated lipocalin with the severity of coronary artery disease. Am J Cardiol 2009; 104: 917-20. [CrossRef]
8. Liu Q, Nilsen-Hamilton M. Identification of a new acute phase protein. J Biol Chem 1995; 270: 22565-70. [CrossRef]
9. Kratchmarova I, Kalume DE, Blagoev B, Scherer PE, Podtelejnikov AV, Molina H, et al. A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol Cell Proteomics 2002; 1: 213-22. [CrossRef]
10. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 2006; 333: 1091. [CrossRef]
11. Gensini GG. A more meaningful scoring system for determining the severity of coronary artery disease. Am J Cardiol 1983; 51: 606. [CrossRef]
12. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary- artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-72. [CrossRef]
13. SYNTAX working group. SYNTAX score calculator. Available at http://www.syntaxscore.com. Accessed May 20, 2012.
14. Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation 1995; 91: 2125-31. [CrossRef]
15. Loftus IM, Naylor AR, Goodall S, Crowther M, Jones L, Bell PR, et al. Increased matrix metalloproteinase-9 activity in unstable carotid plaques: a potential role in acute plaque disruption. Stroke 2000; 31: 40-7. [CrossRef]
16. Yan L, Borregaard N, Kjeldsen L, Moses MA. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 2001; 276: 37258-65. [CrossRef]
17. Şahinarslan A, Kocaman SA, Baş D, Akyel A, Erçin U, Zengin O, et al. Plasma neutrophil gelatinase-associated lipocalin levels in acute myocardial infarction and stable coronary artery disease. Coron Artery Dis 2011; 22: 333-8. [CrossRef]
18. Lemesle G, Bonello L, de Labriolle A, Steinberg DH, Roy P, Pinto Slottow TL, et al. Prognostic value of the SYNTAX score in patients undergoing coronary artery bypass grafting for three-vessel coronary artery disease. Catheter Cardiovasc Interv 2009; 73: 612-7. [CrossRef]
19. Capodanno D, Di Salvo ME, Cincotta G, Miano M, Tamburino C, Tamburino C. Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv 2009; 2: 302-8. [CrossRef]
20. Karakaş MF, Büyükkaya E, Kurt M, Motor S, Akçay AB, Büyükkaya S, et al. Serum pentraxin 3 levels are associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris. J Investig Med 2013; 61: 278-85.
21. Griva M, Naplava R, Spendlikova M, Jarkovsky J, Hlinomaz O, Cihalik C. Potential role of selected biomarkers for predicting the presence and extent of coronary artery disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2010; 154: 219-25. [CrossRef]
22. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004; 291: 2727-33. [CrossRef]
23. Elneihoum AM, Falke P, Hedblad B, Lindgarde F, Ohlsson K. Leukocyte activation in atherosclerosis: correlation with risk factors. Atherosclerosis 1997; 131: 79-84. [CrossRef]
24. Bolignano D, Donato V, Coppolino G, Campo S, Buemi A, Lacquaniti A, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis 2008; 52: 595-605. [CrossRef]
25. Bolignano D, Coppolino G, Campo S, Aloisi C, Nicocia G, Frisina N, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients. Nephrol Dial Transplant 2008; 23: 414-6. [CrossRef]
26. Torregrosa I, Montoliu C, Urios A, Elmlili N, Puchades MJ, Solís MA, et al. Early biomarkers of acute kidney failure after heart angiography or heart surgery in patients with acute coronary syndrome or acute heart failure. Nefrologia 2012; 32: 44-52.
27. Yan QW, Yang Q, Mody N, Graham TE, Hsu CH, Xu Z, et al. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 2007; 56: 2533-40. [CrossRef]
28. Wang Y, Lam KS, Kraegen EW, Sweeney G, Zhang J, Tso AW, et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, hyperglycemia in humans. Clin Chem 2007; 53: 34-41. [CrossRef]